Product Description: Colivelin TFA is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3?in vitro[1]. Colivelin TFA exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease[2]. Colivelin TFA has the potential for the treatment of alzheimer's disease and ischemic brain injury[1].
Applications: Neuroscience-Neurodegeneration
Formula: C119H206N32O35.C2HF3O2
Citations: Ann Transl Med. 2020 Nov;8(21):1346./Antiviral Res. January 2022, 105228./Biochem Cell Biol. 2022 Nov 1./Biochem Cell Biol. 2022 Oct 20./Biomed Pharmacother. 2020 Nov;131:110541./Biomol Biomed. 2024 Aug 2./Brain Res Bull. 2024 Nov 13:219:111128./Cell Commun Signal. 2021 Nov 16;19(1):115./Exp Ther Med. March 1, 2022./Frigid Zone Medicine. 20 May 2022./Front Mol Biosci. 2021 Jun 18;8:654766./Inflamm Bowel Dis. 2023 Jun 19;izad099./Int Immunopharmacol. 2024 Apr 25:133:112126./Int Immunopharmacol. 2024 Oct 18;143(Pt 2):113416./Int J Biol Sci. 2023 Mar./Int J Neurosci. 2021 Jan;131(1):15-24./J Agric Food Chem. 2021 Jul 6./J Inflamm Res. 24 May 2022./J Nanobiotechnology. 2024 Jun 19;22(1):345./Nat Commun. 2021 Nov 25;12(1):6891./PeerJ. 2022 Sep 28;10:e14086./Phytomedicine. 2022: 154551./Phytomedicine. 2023 Apr 3, 154799./Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2122099119./Research Square Preprint. 2020 Dec./Vascul Pharmacol. 2024 Jul 17:107411./Adv Rheumatol. 2024 Dec 18;64(1):88./Aging. 2020 May 15;12(10):9066-9084./Biochim Biophys Acta Mol Basis Dis. 2023 Dec 6:166979./Cancer Immunol Immunother. 2022 Jun 20./Cell Signal. 2020 Jul;71:109606./CNS Neurosci Ther. 2023 Oct 23./Commun Biol. 2022 Dec 1;5(1):1316./Drug Dev Res. 2022 Oct 2./Ecotoxicol Environ Saf. 2024 Aug 12:283:116857./Free Radic Biol Med. 2024 Aug 28:S0891-5849(24)00630-0./Inflammation. 2024 Jun 17./Int J Mol Sci. 2024 Mar 3, 25(5), 2950./Int J Nanomedicine. 2023 Nov 28./J Ethnopharmacol. 2024 Sep 13:118829./J Nanobiotechnology. 2024 Aug 24;22(1):509./J Nanobiotechnology. 2024 Jul 11;22(1):409./J Nat Med. 2020 Jun;74(3):533-544. /J Physiol Sci. 2024 Feb 16./Mol Biol Rep. 2024 Jan 22;51(1):176./Oncol Rep. 2024 May;51(5):71./Phytomedicine. 2024 Mar 22, 155563./Redox Biol. 2023 Nov 7, 102956./Sci Transl Med. 2021 Oct 6;13(614):eabg6428./SSRN. 2024 Apr 7./Tissue Cell. 2024 Nov 30:93:102645./World J Stem Cells. 2024 Nov 26;16(11):906-925.
References: [1]Chiba T, et al. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. J Neurosci. 2005 Nov 2;25(44):10252-61./[2]Zhao H, et al. Colivelin Rescues Ischemic Neuron and Axons Involving JAK/STAT3 Signaling Pathway.Neuroscience. 2019 Sep 15;416:198-206./[3]Pan Z, et al. Upregulation of HSP72 attenuates tendon adhesion by regulating fibroblast proliferation and collagen production via blockade of the STAT3 signaling pathway.Cell Signal. 2020 Mar 18:109606./[4]Fang YY, et al. MFG-E8 alleviates oxygen-glucose deprivation-induced neuronal cell apoptosis by STAT3 regulating the selective polarization of microglia. Int J Neurosci. 2020 Mar 12:1-10./[5]Chiu WC, et al. The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways. PLoS One. 2016 Nov 22;11(11):e0166453.
CAS Number: 2803948-60-7
Molecular Weight: 2759.12
Compound Purity: 99.52
Research Area: Neurological Disease
Solubility: H2O : 50 mg/mL (ultrasonic)
Target: Amyloid-β;Apoptosis;STAT
Deutsch
English
